T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$7.49B |
| 2 |
Micron Technology
MU
|
+$6.62B |
| 3 |
Lam Research
LRCX
|
+$3.45B |
| 4 |
Applied Materials
AMAT
|
+$3.03B |
| 5 |
Advanced Micro Devices
AMD
|
+$2.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$12.1B |
| 2 |
Apple
AAPL
|
+$11.6B |
| 3 |
Amazon
AMZN
|
+$3.54B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.07B |
| 5 |
Keysight
KEYS
|
+$1.82B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.73% |
| 2 | Healthcare | 11.3% |
| 3 | Financials | 10.32% |
| 4 | Communication Services | 9.66% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Globant
GLOB
$1.46B
| $10.9M | ﹤0.01% |
376,286
-886
| -0.2% | -$35.4K |
|
1302
Primoris Services
PRIM
$3.83B
| $10.8M | ﹤0.01% |
109,041
-605,480
| -85% | -$79.6M |
|
1303
Hecla Mining
HL
$11.4B
| $10.8M | ﹤0.01% |
698,999
-76,863
| -10% | -$1.35M |
|
1304
OFG Bancorp
OFG
$2.16B
| $10.8M | ﹤0.01% |
219,726
-4,791
| -2% | -$217K |
|
1305
Carlyle Group
CG
$14.1B
| $10.7M | ﹤0.01% |
255,243
+18,694
| +8% | +$878K |
|
1306
Old National Bancorp
ONB
$9.64B
| $10.7M | ﹤0.01% |
413,176
+63,866
| +18% | +$1.53M |
|
1307
Five Below
FIVE
$12.6B
| $10.6M | ﹤0.01% |
58,916
-62,063
| -51% | -$13.4M |
|
1308
Kyverna Therapeutics
KYTX
$422M
| $10.6M | ﹤0.01% |
1,186,023
-369,264
| -24% | -$3.28M |
|
|
BLD
1309
DELISTED
TopBuild
BLD
| $10.6M | ﹤0.01% |
29,760
-82,668
| -74% | -$34.1M |
|
1310
SPS Commerce
SPSC
$2.92B
| $10.5M | ﹤0.01% |
184,383
-35,026
| -16% | -$1.93M |
|
|
ARES.PRB
1311
Ares Management Corp 6.75% Series B Preferred Stock
ARES.PRB
$1.16B
| – | – |
0
| – | – |
|
1312
Wave Life Sciences
WVE
$723M
| $10.5M | ﹤0.01% |
1,806,467
-6,898,083
| -79% | -$45.7M |
|
|
PURR
1313
Hyperliquid Strategies Inc
PURR
$2.39B
| $10.4M | ﹤0.01% |
+1,320,743
| New | +$9.77M |
|
1314
OGE Energy
OGE
$9.23B
| $10.4M | ﹤0.01% |
213,286
+9,223
| +5% | +$441K |
|
1315
Olema Pharmaceuticals
OLMA
$753M
| $10.3M | ﹤0.01% |
826,569
-356,267
| -30% | -$4.77M |
|
1316
Lumen
LUMN
$5.7B
| $10.3M | ﹤0.01% |
1,340,394
+192,821
| +17% | +$1.69M |
|
1317
Amalgamated Financial
AMAL
$1.41B
| $10.2M | ﹤0.01% |
222,635
+42,233
| +23% | +$1.78M |
|
1318
Ingredion
INGR
$6.08B
| $10.2M | ﹤0.01% |
107,609
-36,782
| -25% | -$3.89M |
|
1319
Movado Group
MOV
$747M
| $10.2M | ﹤0.01% |
258,543
+64,994
| +34% | +$2.03M |
|
1320
Hanmi Financial
HAFC
$937M
| $10.1M | ﹤0.01% |
312,194
+83,425
| +36% | +$2.49M |
|
1321
Arcosa
ACA
$7.2B
| $10.1M | ﹤0.01% |
69,477
-212,921
| -75% | -$26.4M |
|
1322
Iovance Biotherapeutics
IOVA
$4.98B
| $10.1M | ﹤0.01% |
2,415,456
-751,405
| -24% | -$2.85M |
|
1323
Wintrust Financial
WTFC
$9.72B
| $9.94M | ﹤0.01% |
61,831
+4,674
| +8% | +$703K |
|
1324
Perdoceo Education
PRDO
$1.88B
| $9.87M | ﹤0.01% |
308,432
+177,518
| +136% | +$6.09M |
|
|
CNH
1325
CNH Industrial
CNH
$21.3B
| $9.86M | ﹤0.01% |
877,862
+116,701
| +15% | +$1.24M |
|
Similar funds
T. Rowe Price Associates's Q2 2026 Portfolio in Review
As of Q2 2026, T. Rowe Price Associates held 3,356 positions worth $999B, up 16% from $865B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q2 2026 filing shows 224 new, 2,237 increased, 645 reduced and 116 closed positions. Its largest new stake was SpaceX: 10,709,016 shares worth $1.83B. The largest sale was Microsoft, an estimated $12.1B.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 34% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2026 buy was SpaceX: 10,709,016 shares worth $1.83B.
- T. Rowe Price Associates added most to Alphabet (Google) Class A in Q2 2026, an estimated $7.49B increase.
- T. Rowe Price Associates's biggest Q2 2026 reduction was Microsoft, cutting an estimated $12.1B.
- T. Rowe Price Associates fully exited Sibanye-Stillwater in Q2 2026, selling an estimated $40.4M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $999B portfolio in Q2 2026.
- T. Rowe Price Associates opened 224 new positions and closed 116 in Q2 2026.
- T. Rowe Price Associates's portfolio value rose 16% quarter-over-quarter to $999B.
Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.